- Home
- XTNT vs VNRX Comparison
XTNT vs VNRX Comparison
Compare XTNT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- VNRX
- Stock Information
- Founded
- XTNT N/A
- VNRX N/A
- Country
- XTNT United States
- VNRX United States
- Employees
- XTNT N/A
- VNRX N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- XTNT Health Care
- VNRX Health Care
- Exchange
- XTNT Nasdaq
- VNRX Nasdaq
- Market Cap
- XTNT 74.1M
- VNRX 67.2M
- IPO Year
- XTNT N/A
- VNRX N/A
- Fundamental
- Price
- XTNT $0.40
- VNRX $0.79
- Analyst Decision
- XTNT Strong Buy
- VNRX Strong Buy
- Analyst Count
- XTNT 1
- VNRX 4
- Target Price
- XTNT $3.00
- VNRX $4.17
- AVG Volume (30 Days)
- XTNT 105.5K
- VNRX 156.8K
- Earning Date
- XTNT 11-12-2024
- VNRX 11-14-2024
- Dividend Yield
- XTNT N/A
- VNRX N/A
- EPS Growth
- XTNT N/A
- VNRX N/A
- EPS
- XTNT N/A
- VNRX N/A
- Revenue
- XTNT $113,862,000.00
- VNRX $1,285,827.00
- Revenue This Year
- XTNT $31.82
- VNRX $180.66
- Revenue Next Year
- XTNT $13.64
- VNRX $558.69
- P/E Ratio
- XTNT N/A
- VNRX N/A
- Revenue Growth
- XTNT 45.11
- VNRX 97.50
- 52 Week Low
- XTNT $0.39
- VNRX $0.43
- 52 Week High
- XTNT $1.45
- VNRX $1.23
- Technical
- Relative Strength Index (RSI)
- XTNT 22.17
- VNRX 64.33
- Support Level
- XTNT $0.39
- VNRX $0.64
- Resistance Level
- XTNT $0.54
- VNRX $0.80
- Average True Range (ATR)
- XTNT 0.03
- VNRX 0.08
- MACD
- XTNT -0.01
- VNRX 0.02
- Stochastic Oscillator
- XTNT 12.81
- VNRX 91.27
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.